Thursday, November 16th, 2017

10:00-10:45 Registration
11:00 -11:30 Welcome and introduction
Rosa Asbert. Medical Director. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Lluis Cirera. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
11:30-14:00 Sponsored symposia
14:00-15:15 Lunch
14:15-20:00 Poster display
15:15-16:40 INTERACTIVE SESSION 1: Clinical case with multidisciplinary team discussion. Patient with liver metastases and peritoneal carcinomatosis

Moderators:
Esteban Cugat. Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
Lluis Cirera. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
15:15-15:45 Clinical case presentation
Comments: Pedro Barrios. Oncology Surgery Service. Hospital Sant Joan Despí Moisès Broggi. Sant Joan Despí
15:45-16:00 Surgery of Liver Metastases: How far should we go?
René Adam. Oncosurgical Unit. Hepatobiliary Center. University Paris Sud. Hôpital Paul-Brousse. Paris
16:00-16:15 Radiological disappearance of hepatic metastases after systemic treatment: What can we do?
Miguel Ángel Gomez Bravo. Surgery and trasplantation Unit. Hospital Universitario Virgen del Rocio. Sevilla
16:15-16:30 Minimal residual disease: a new paradigm
Ramón Salazar. Medical Oncology. Institut Català de Oncologia. Barcelona
16:30-16:40 Discussion
16:40-17:10 LECTURE

Introduction:
Eric Herrero. Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Fernando Pardo. Hepatobiliary Surgery Service. Clínica Universitaria de Navarra. Pamplona. Navarra
16:40-17:00 Staged hepatectomy: to rush with ALPPS or to wait with conventional two-stage?
René Adam. Oncosurgical Unit. Hepatobiliary Center. University Paris Sud. Hôpital Paul-Brousse. Paris
17:00-17:10 Questions
17:10-17:40 Coffe break
17:40-18:50 LIVER METASTASES

Moderators:
Maribel García Domingo. Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
Miguel Ángel Gomez Bravo. Surgery and trasplantation Unit. Hospital Universitario Virgen del Rocio. Sevilla
17:40-18:10 Benefits of laparoscopic liver resection
Rubén Ciria. Surgery Service. University Hospital Reina Sofia. Córdoba
18:10-18:25 Metastases resection after Aflibercept in second-line chemotherapy
Andrés Muñoz. Oncology Service. Hospital Gregorio Marañón. Madrid
18:25-18:40 Liver surgery before primary tumour resection
Fernando Pardo. Hepatobiliary Surgery Service. Clínica Universitaria de Navarra. Pamplona. Navarra
18:40-18:50 Discussion
18:50-19:30 LECTURE

Introduction: Marta Paraira. Radiodiagnostic Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
18:50-19:00 Liver imaging: MRI or CT?
Judith Camps. Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
19:00-19:20 Genomics and radiogenomics
Luis Marti-Bonmati. Radiology Service. Hospital Universitario y Politécnico La Fe. Valencia
19:20-19:30 Questions

Friday, November 17th, 2017

8:00-8:55 INTERACTIVE SESSION 2: Clinical case with multidisciplinary team discussion. Patient with lung and liver metastases

Moderators:
Mireia Serra. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Julen Fernández. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
8:00-8:30 Clinical case presentation
8:30-8:45 Biomarkers for selection of chemotherapy
David Paez. Medical Oncology Service. Hospital de la Santa Creu i Sant Pau. Barcelona
8:45-8:55 Discussion
8:55-9:25 LECTURE

Introduction:
Ramón Rami-Porta. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Laureano Molins. Thoracic Surgery Service. Hospital Clínic. Hospital Universitari Sagrat Cor. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
8:55-9:15 Surgery and ablative techniques for treatment of lung metastases of colorectal cancer: past, present and future
Tom Treasure. Clinical Operational Research Unit. University College London. London
9:15-9:25 Questions
9:25-9:45 Coffe break
9:45-10:55 LUNG METASTASES

Moderators:
Sergi Call. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Ramón Rami-Porta. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa
9:45-10:00 Surgery for lung metastases of colorectal carcinoma. Do we believe in what we do? Results from the Survey of the Spanish Society of Thoracic Surgery
Raúl Embún. Department of Thoracic Surgery. Hospital Universitario Miguel Servet. Zaragoza
10:00-10:15 Role of major lung resections in the surgical treatment of lung metastases of colorectal carcinoma
Jorge Hernández. Thoracic Surgery Unit. Hospital Universitari del Sagrat Cor. Barcelona
10:15-10:30 Technical aspects of laser resection of lung metastases
Sebastian Wiesemann. Department of Thoracic Surgery. University Medical Center Freiburg. Freiburg
10:30-10:45 Isolated lung perfusion and related techniques for treatment of pulmonary metastasis. Is survival really improved?
Paul Van Schil. Department of Thoracic and Vascular Surgery. University Hospital of Antwerp. Edegem
10:45-10:55 Discussion
10:55-11:25 LECTURE

Introduction: Pedro Barrios. Oncology Surgery Service. Hospital Sant Joan Despí Moisès Broggi. Sant Joan Despí
10:55-11:15 Management for peritoneal metastases: an update
Paul H. Sugarbaker. Medical Director. Center for Gastrointestinal Malignancies Chief. Program in Peritoneal Surface Oncology. MedStar Washington Hospital Center. Washington
11:15-11:25 Questions
11:25-13:05 INTERACTIVE SESSION 3: Clinical case with multidisciplinary team discussion. Patient with peritoneal carcinomatosis

Moderators:
Esther Casado. Oncology Service. Althaia. Xarxa Assistencial de Manresa. Manresa. Barcelona
María Isabel Ramos. Oncology Surgery Service. Hospital Sant Joan Despí Moisès Broggi. Sant Joan Despí
11:25-11:55 Clinical case presentation
11:55-12:10 Pathophysiology of colorectal peritoneal carcinomatosis
Paul H. Sugarbaker. Medical Director. Center for Gastrointestinal Malignancies Chief. Program in Peritoneal Surface Oncology. MedStar Washington Hospital Center. Washington
12:10-12:25 Diagnostic imaging in peritoneal carcinomatosis
Nadine Romera. Radiology Service. Hospital Quirónsalud. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
12:25-12:40 Immune chekpoints and immunotherapy for mCRC
Ferrán Losa. Oncology Surgery Service. Hospital Sant Joan Despí Moisès Broggi. Sant Joan Despí
12:40-12:55 Outcomes in the care of peritoneal carcinomatosis in the Catalonian public health system
José María Borrás. University of Barcelona and Catalonian Cancer Strategy
12:55-13:05 Discussion
13:05-13:35 LECTURE

Introduction: Lluis Cirera. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa -Centro Médico Teknon. Grupo Quirónsalud. Barcelona
13:05-13:25 Sidedness or molecular profile
Jesús García-Foncillas. Oncology Department. Fundación Jiménez Díaz. Madrid
13:25-13:35 Questions
13:35-14:10 POSTER SESSION
  1. Increase in splenic volume predicts hepatic injury in patients with colorrectal liver metastases treated with chemotherapy
    Patricia Saez Carlin, Alejandra García Botella, Luis Díez Valladares, Ramiro Méndez Fernández, Luis Ortega Medina, Antonio Torres García
    Hospital Clínico San Carlos, Madrid. Spain
  2. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection
    Alejandra García Botella, Patricia Sáez Carlin, Luis Ignacio Díez Valladares, Rocio Avellana, Luis Ortega Medina, Ramiro Méndez Fernández, Javier Armijo, Antonio Torres García
    Hospital Clínico San Carlos, Madrid. Spain
  3. Oncological strategies in rectal cancer with liver metastases
    Lucas Casalduero García, Alberto Carabias Hernández, Carlos José Gamo Albero, Paloma Sanz Muñoz, Alvaro Sobrino Grande, Ana Serantes, Miguel Ángel Delgado, Jose María Jover Navalón
    Hospital Universitario de Getafe, España
  4. Utility of 3D printing model reconstruction in complex hepatic surgery. Our experience
    Luque Molina, A1; Alcalá, L2; López León, M3; López Martínez, C1; Jodral, T1; Luna Alcalá2, A; López Cillero, P3
    1 Unidad de Cirugía HBP HSJDD Córdoba; 2 Servicio Radiología HSJDD Córdoba; 3 Facultad de Medicina Universidad de Córdoba
  5. Oligometastasic colorectal cancer (CRC) lung metastases treated with stereotactic body radiotherapy (SBRT), experience of "Hospital Universitario Donostia"
    María Otaño1, M.Aránzazu Bujedo1, Ana Landa1, M.Ángeles Díaz1, Daniel Roura2, M.Eguzki Iraolagoitia2, Leyre González2, Julian Minguez2, Adelaida La Casta1
    1 Medical Oncology, Hospital Universitario Donostia; 2 Radiotherapic Oncology, Hospital Universitario Donostia. San Sebastian, Spain
  6. Wound recurrence: a rare event after colorectal hepatic metastases surgery
    A. Landa Magdalena; A. La Casta Muñoa; M. Otaño Ariño; MA. Diaz Gallego; M. Alkorta Zuloaga
    Hospital Universitario Donostia. San Sebastian. Spain
  7. Location of colorectal cancer as a prognosis factor and a predictor in our area
    Jose Carlos Benítez1 MD, Julen Fernandez1 MD, Carmen Ferrer2 MD, José Ángel de Marcos3 MD, Marta Paraira3 MD, Luis Cirera1 MD
    1 Department of Medical Oncology. Hospital Universitari Mutua Terrassa. Terrassa, University of Barcelona, Barcelona, Spain
    2 Department of Pathology. Hospital Universitari Mutua Terrassa. Terrassa, University of Barcelona, Barcelona, Spain
    3 Department of Radiology. Hospital Universitari Mutua Terrassa. Terrassa, University of Barcelona, Barcelona, Spain
14:10-14:15 BEST POSTER AWARD
14:15-14:20 Closing
14:20 LUNCH